Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2005-09-20
2005-09-20
Page, Thurman K. (Department: 1615)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
Reexamination Certificate
active
06946487
ABSTRACT:
This invention relates to the interconversion of inactive 11-keto steroids with their active 11B-hydroxy equivalents, to methods by which the conversion of the inactive to the active from may be controlled, and to useful therapeutic effects which may be obtained as a result of such control. More specifically, but not exclusively, the invention is concerned with interconversion between cortisone and cortisol in humans.
REFERENCES:
Stewart et al., J. Steroid Biochem. Molec. Biol., vol. 40, pp. 501-509, 1990.
Edwards Christopher Richard Watkin
Seckl Jonathan Robert
Walker Brian Robert
Frommer Lawrence & Haug
Kowalski Thomas J.
Page Thurman K.
University of Edinburgh
LandOfFree
Regulation of intracellular glucocorticoid concentrations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Regulation of intracellular glucocorticoid concentrations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Regulation of intracellular glucocorticoid concentrations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3380309